[go: up one dir, main page]

BRPI0519199A2 - composiÇço de viscossuplemento e uso da mesma - Google Patents

composiÇço de viscossuplemento e uso da mesma

Info

Publication number
BRPI0519199A2
BRPI0519199A2 BRPI0519199-8A BRPI0519199A BRPI0519199A2 BR PI0519199 A2 BRPI0519199 A2 BR PI0519199A2 BR PI0519199 A BRPI0519199 A BR PI0519199A BR PI0519199 A2 BRPI0519199 A2 BR PI0519199A2
Authority
BR
Brazil
Prior art keywords
composition
viscossuplement
viscossuplementos
compositions
release
Prior art date
Application number
BRPI0519199-8A
Other languages
English (en)
Inventor
Guohua Chen
Edwin Chan
Joe Rosenblatt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BRPI0519199A2 publication Critical patent/BRPI0519199A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIÇçO DE VISCOSSUPLEMENTO E USO DA MESMA. A presente invenção refere-se a métodos e composições de depósito de emulsão para a liberação de viscossuplementos.
BRPI0519199-8A 2004-12-23 2005-12-20 composiÇço de viscossuplemento e uso da mesma BRPI0519199A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63853504P 2004-12-23 2004-12-23
US11/305,939 US20060140988A1 (en) 2004-12-23 2005-12-19 Visco-supplement composition and methods
PCT/US2005/046446 WO2006071694A1 (en) 2004-12-23 2005-12-20 Visco-supplement composition and methods

Publications (1)

Publication Number Publication Date
BRPI0519199A2 true BRPI0519199A2 (pt) 2008-12-30

Family

ID=36169128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519199-8A BRPI0519199A2 (pt) 2004-12-23 2005-12-20 composiÇço de viscossuplemento e uso da mesma

Country Status (14)

Country Link
US (1) US20060140988A1 (pt)
EP (1) EP1827376A1 (pt)
JP (1) JP2008525471A (pt)
KR (1) KR20070091302A (pt)
AR (1) AR052182A1 (pt)
AU (1) AU2005322231A1 (pt)
BR (1) BRPI0519199A2 (pt)
CA (1) CA2587388A1 (pt)
IL (1) IL184062A0 (pt)
MX (1) MX2007007826A (pt)
NO (1) NO20073762L (pt)
RU (1) RU2007127835A (pt)
TW (1) TW200640496A (pt)
WO (1) WO2006071694A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60311958T2 (de) * 2003-02-03 2007-11-08 Polaschegg, Hans-Dietrich, Dr. Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
UY33517A (es) * 2010-07-19 2012-02-29 Astrazeneca Ab Depósito farmacéutico para 5-fluoro-2-[[(1S)-1-(5-fluoro-2-piridil)etil]amino]-6-[(5-isopropoxi-1H-pirazol-3-il)amino]piridin-3-carbonitrilo?.
WO2013076162A1 (en) 2011-11-21 2013-05-30 Université Libre de Bruxelles Formulations useful in the treatment of osteoarticular diseases
US10245306B2 (en) * 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
WO2015018461A1 (fr) * 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
EP3237013B1 (en) 2014-12-23 2023-06-07 Steven Hoffman Transdermal formulations
IT201800007683A1 (it) 2018-07-31 2020-01-31 Altergon Sa Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
CA3197170A1 (en) * 2020-09-30 2022-04-07 Tolmar International Limited Biodegradable polymer and solvent compositions and systems for extended storage and delivery of active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
ITFI980104A1 (it) * 1998-05-04 1999-11-04 Hibiscus S R L Composizioni stabilizzate contenenti acido ialuronico,loro preparazione ed uso
US7582311B1 (en) * 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
EP1370610B1 (en) * 2000-11-28 2008-09-10 Genzyme Corporation Polyalkylene glycol viscosity-enhancing polymeric formulations

Also Published As

Publication number Publication date
AU2005322231A1 (en) 2006-07-06
MX2007007826A (es) 2007-07-25
WO2006071694A1 (en) 2006-07-06
AR052182A1 (es) 2007-03-07
TW200640496A (en) 2006-12-01
IL184062A0 (en) 2007-10-31
CA2587388A1 (en) 2006-07-06
RU2007127835A (ru) 2009-01-27
EP1827376A1 (en) 2007-09-05
NO20073762L (no) 2007-09-14
JP2008525471A (ja) 2008-07-17
US20060140988A1 (en) 2006-06-29
KR20070091302A (ko) 2007-09-10

Similar Documents

Publication Publication Date Title
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
CR20160206A (es) Composiciones y métodos para anticuerpos que se dirigen a la proteína de complemento C5
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
ECSP088800A (es) Formulaciones de inhibidores de DPP IV
PA8796201A1 (es) Agentes anti-infecciosos y su uso
AR057253A1 (es) Anticuerpos anti-ox40l y metodos que los utilizan
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
UY31806A (es) Compuestos de tiazole y oxazole de sulfonamida de benceno
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
CL2010001530A1 (es) Compuestos derivados de tiadiazoliloxifenilamidinas; su procedimiento de preparacion; agentes para combatir microorganismos indeseados que comprende a dichos compuestos; uso; procedimiento para combatir microorganismos indeseados; y compuestos intermediarios.
GT200900292A (es) "inhibidores de cinasa p70 s6"
CR20150088A (es) Anticuerpos anti-notch1 nrr
DOP2015000264A (es) Derivados de azaadamantano y métodos de uso de los mismos
CU23871B1 (es) Composiciones y métodos de uso para anticuerpos de dickkopf-1
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
ECSP11011344A (es) Nuevos anticuerpos anti-?5?1 y sus usos
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
CR11861A (es) Compuestos organicos
SV2009003187A (es) 4-[4-({[4-cloro-3-(trifluorometil) fenil] carbamoil} amino)-3-fluorofenoxi]-n-metilpiridina-2-carboxamida monohidrato
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
ECSP088743A (es) Anticuerpos para egfl7 y métodos para su uso
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]